×
IonQ Inc
↓ 30.38% Fall from 52W High
  • INSIDER TRADING
  • CHECKLIST
  • OWNERSHIP
  • TECHNICALS
  • FINANCIALS
  • SWOT
  • OVERVIEW
TECHNICALS OWNERSHIP CHECKLIST DEALS
Strengths 11
Weakness 14
Opportunity 0
Threats 2
  • Strengths
  • Weakness
  • Opportunity
  • Threats
  • Companies with 10% increase in share price over three months, with rising net profit growth
  • Relative Outperformance versus Industry over the Quarter (3 Months)
  • PEG lower than Industry PEG
  • High Momentum Scores (Technical Scores greater than 50)
  • Relative Outperformance versus Industry over 1 Week
  • Companies with Low Debt
  • Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
  • Stock with Low PE (PE < = 10)
  • RSI indicating price strength
  • Highest Recovery from 52 Week Low
  • Stocks Outperforming their Industry Price Change in the Quarter
  • Negative Breakdown Second Support (LTP < S2)
  • Momentum Trap (DVM)
  • Stocks with Expensive Valuations according to the Trendlyne Valuation Score
  • Low durability companies
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years
  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
  • Top Losers
  • Negative Breakdown First Support (LTP < S1)
  • Negative Breakdown Second Support (LTP < S2)
  • Low Piotroski Score : Companies with weak financials
  • Annual net profit declining for last 2 years
  • Declining Revenue every quarter for the past 2 quarters
  • Top Losers
  • No opportunity to display
  • Mutual Funds Decreased Shareholding in Past Month
  • MFs decreased their shareholding last quarter
Note: Financial Information is based on numbers.
Powered by Source: trendlyne.com
Market Capitalization
Below industry Median
9,970.8

PE TTM
Negative PE TTM
-30.7

PEG TTM
Below industry Median
0.3

Price to Book
Below industry Median
13

Operating Profit Margin Qtr %
Negative Operating Profit Margin Qtr %
-1,000.3

Dividend yield 1yr %
 
0

Oper Rev Qtr
0% decr over last year
7.6

Net Profit Qtr
18.5% incr over last year
-32.3

Operating Profit Qtr
43% decr over last year
-75.7

Operating Revenue TTM
69.9% incr over last year
43.1

Net profit TTM
91% decr over last year
-324.3

Basic EPS TTM
91% decr over last year
-1.2

RSI
RSI is mid-range
49.4

MFI
MFI is mid-range
44.6

Last event detail is not available

*All Financial parameters are in Million USD.

IonQ Inc EMA & SMA

38.11 ↓ -6.73%
CURRENT PRICE
Bullish Moving Averages
Bearish Moving Averages
5 Day 39.5

10 Day 39.5

12 Day 39.5

20 Day 39.0
26 Day 38.4

50 Day 36.0

100 Day 32.9

200 Day 28.3
5 Day 40.0

10 Day 39.3

20 Day 40.0

30 Day 39.2
50 Day 34.8

100 Day 31.4

150 Day 33.3

200 Day 28.1

IonQ Inc DELIVERY AND VOLUME

LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator

IonQ Inc RESISTANCE AND SUPPORT

39.43
PIVOT
First Resistance 40.8

Second Resistance 43.5

Third Resistance 44.9
First Support 36.7

Second Support 35.4

Third Support 32.7
Day RSI 49.4

Day MACD 1.1

Day MFI 44.6
Day MACD Signal Line 1.5
+ MORE

Day ADX 25


Day ATR 3.3

Day Commodity Channel Index -33.2

Day ROC125 -14.2

Day ROC21 -16.6
William -73.1
- LESS

IonQ Inc BETA

1 Month 4.8

1 Year 0.5
3 Months 0.3

3 Years 0.1

IonQ Inc PRICE CHANGE ANALYSIS

↓ -16.6%
Over 1 Month
Low High
35.9 48.9
↑ 45.9%
Over 3 Months
Low High
18.8 48.9
↓ -14.0%
Over 6 Months
Low High
17.9 54.7
↑ 463.8%
Over 1 Year
Low High
6.2 54.7
View full Share Price History
Powered by Source: trendlyne.com
Client Name Client Category Action Reported to Exchange Quantity Avg. Price Value Security Type
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.13 per share. 20 Jun 2025 1,497,311 0.1 199,741.00 Common Stock
PETER CHAPMAN Director, Executive Chair Sale of securities on an exchange or to another person at price $ 39.93 per share. 20 Jun 2025 1,497,311 39.9 59,789,126.00 Common Stock
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2025 1,497,311 Employee Stock Option (right to buy)
ROBERT THOMAS CARDILLO Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 5,513 Common Stock
KATHRYN K. CHOU Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 5,513 Common Stock
INDER M. SINGH Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 5,513 Common Stock
WILLIAM FRANCIS SCANNELL Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 5,513 Common Stock
GABRIELLE B. TOLEDANO Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 5,513 Common Stock
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.13 per share. 16 Jun 2025 3,581,193 0.1 477,731.00 Common Stock
PETER CHAPMAN Director, Executive Chair Sale of securities on an exchange or to another person at price $ 38.13 per share. 16 Jun 2025 3,581,193 38.1 136,536,564.00 Common Stock
PETER CHAPMAN Director, Executive Chair Sale of securities on an exchange or to another person at price $ 37.78 per share. 16 Jun 2025 910,740 37.8 34,406,573.00 Common Stock
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jun 2025 3,581,193 Employee Stock Option (right to buy)
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jun 2025 910,740 Employee Stock Option (right to buy)
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.13 per share. 16 Jun 2025 910,740 0.1 121,493.00 Common Stock
THOMAS G. KRAMER Chief Financial Officer Sale of securities on an exchange or to another person at price $ 38.11 per share. 16 Jun 2025 216,000 38.1 8,232,430.00 Common Stock
WENDY K. THOMAS Director Sale of securities on an exchange or to another person at price $ 39.43 per share. 12 Jun 2025 16,696 39.4 658,297.00 Common Stock
WENDY K. THOMAS Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2025 5,000 Stock Option (right to buy)
WENDY K. THOMAS Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.62 per share. 12 Jun 2025 5,000 4.6 23,100.00 Common Stock
INDER M. SINGH Director Sale of securities on an exchange or to another person at price $ 39.18 per share. 12 Jun 2025 43,391 39.2 1,699,873.00 Common Stock
INDER M. SINGH Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2025 10,000 Stock Option (right to buy)
INDER M. SINGH Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.72 per share. 12 Jun 2025 10,000 5.7 57,200.00 Common Stock
ROBERT THOMAS CARDILLO Director Sale of securities on an exchange or to another person at price $ 40.22 per share. 11 Jun 2025 10,058 40.2 404,578.00 Common Stock
RIMA ALAMEDDINE Chief Revenue Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2025 65,000 Employee Stock Option (right to buy)
RIMA ALAMEDDINE Chief Revenue Officer Sale of securities on an exchange or to another person at price $ 41.60 per share. 11 Jun 2025 19,976 41.6 830,910.00 Common Stock
RIMA ALAMEDDINE Chief Revenue Officer Sale of securities on an exchange or to another person at price $ 38.57 per share. 11 Jun 2025 65,000 38.6 2,506,758.00 Common Stock
RIMA ALAMEDDINE Chief Revenue Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.65 per share. 11 Jun 2025 65,000 4.7 302,250.00 Common Stock
KATHRYN K. CHOU Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2025 14,000 Stock Option (right to buy)
KATHRYN K. CHOU Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.61 per share. 11 Jun 2025 14,000 4.6 64,540.00 Common Stock
KATHRYN K. CHOU Director Sale of securities on an exchange or to another person at price $ 40.46 per share. 11 Jun 2025 25,696 40.5 1,039,768.00 Common Stock
PETER CHAPMAN Director, Executive Chair Sale of securities on an exchange or to another person at price $ 41.60 per share. 11 Jun 2025 11,965 41.6 497,689.00 Common Stock
THOMAS G. KRAMER Chief Financial Officer Sale of securities on an exchange or to another person at price $ 41.60 per share. 11 Jun 2025 9,994 41.6 415,704.00 Common Stock
GABRIELLE B. TOLEDANO Director Sale of securities on an exchange or to another person at price $ 41.50 per share. 11 Jun 2025 792 41.5 32,868.00 Common Stock
WILLIAM FRANCIS SCANNELL Director Purchase of securities on an exchange or from another person at price $ 21.81 per share. 12 Mar 2025 93,066 21.8 2,029,509.00 Common Stock
RIMA ALAMEDDINE Chief Revenue Officer Sale of securities on an exchange or to another person at price $ 18.57 per share. 11 Mar 2025 20,047 18.6 372,263.00 Common Stock
PETER CHAPMAN Director, Executive Chair Sale of securities on an exchange or to another person at price $ 18.57 per share. 11 Mar 2025 12,069 18.6 224,115.00 Common Stock
THOMAS G. KRAMER Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.57 per share. 11 Mar 2025 11,712 18.6 217,486.00 Common Stock
PETER CHAPMAN Director, Executive Chair Sale of securities on an exchange or to another person at price $ 18.72 per share. 11 Mar 2025 2,000,000 18.7 37,446,600.00 Common Stock
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Mar 2025 2,000,000 Stock Option (right to buy)
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.13 per share. 11 Mar 2025 2,000,000 0.1 260,000.00 Common Stock
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.63 per share. 11 Mar 2025 471,606 7.6 3,598,354.00 Common Stock
PETER CHAPMAN Director, Executive Chair Sale of securities on an exchange or to another person at price $ 18.72 per share. 11 Mar 2025 2,000,000 18.7 37,446,600.00 Common Stock
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Mar 2025 1,528,394 Stock Option (right to buy)
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Mar 2025 471,606 Stock Option (right to buy)
PETER CHAPMAN Director, Executive Chair Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.13 per share. 11 Mar 2025 1,528,394 0.1 198,691.00 Common Stock
RIMA ALAMEDDINE Chief Revenue Officer Sale of securities on an exchange or to another person at price $ 21.20 per share. 06 Mar 2025 1,407 21.2 29,834.00 Common Stock
GABRIELLE B. TOLEDANO Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 1,584 Common Stock
THOMAS G. KRAMER Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 2,948 Common Stock
THOMAS G. KRAMER Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 27,160 Common Stock
RIMA ALAMEDDINE Chief Revenue Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 19,753 Common Stock
RIMA ALAMEDDINE Chief Revenue Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 2,948 Common Stock
Security Type:  Share/ Warrants / Convertible Debentures
Client Category:  Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Data as reported to USA Exchanges
Powered by Source: trendlyne.com